 | • レポートコード：GIR-2104Z11797 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、組換えDNA技術のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。組換えDNA技術の種類別市場規模（治療薬、ワクチン、遺伝子組換え作物、特殊化学品）、用途別市場規模（バイオテクノロジー・製薬会社、学術・政府研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・組換えDNA技術の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Monsanto Company、Roche、Biogen、Amgen、Novartis、Eli Lilly and Company、GenScript、Pfizer Inc.、Novo Nordisk、Sanofi、Merck KGaA、Profacgen、Biocon、GlaxoSmithKline、Cibus、Horizon Discovery Group、New England Biolabs ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：治療薬、ワクチン、遺伝子組換え作物、特殊化学品 ・用途別分析2016年-2026年：バイオテクノロジー・製薬会社、学術・政府研究所、その他 ・組換えDNA技術の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・組換えDNA技術のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・組換えDNA技術のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・組換えDNA技術の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・組換えDNA技術の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant DNA Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant DNA Technology size is estimated to be USD 585 million in 2025 from USD 505 million in 2019, with a change XX% between 2019 and 2020. The global Recombinant DNA Technology market size is expected to grow at a CAGR of 3.7% for the next five years.
Market segmentation
Recombinant DNA Technology market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Market segment by Application, can be divided into
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Market segment by players, this report covers
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Recombinant DNA Technology
1.2 Classification of Recombinant DNA Technology by Type
1.2.1 Overview: Global Recombinant DNA Technology Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Recombinant DNA Technology Revenue Market Share by Type in 2020
1.2.3 Therapeutic Agent
1.2.4 Vaccine
1.2.5 Biotech Crops
1.2.6 Specialty Chemicals
1.3 Global Recombinant DNA Technology Market by Application
1.3.1 Overview: Global Recombinant DNA Technology Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Global Recombinant DNA Technology Market Size & Forecast
1.5 Global Recombinant DNA Technology Market Size and Forecast by Region
1.5.1 Global Recombinant DNA Technology Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Recombinant DNA Technology Market Size by Region, (2016-2021)
1.5.3 North America Recombinant DNA Technology Market Size and Prospect (2016-2026)
1.5.4 Europe Recombinant DNA Technology Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Recombinant DNA Technology Market Size and Prospect (2016-2026)
1.5.6 South America Recombinant DNA Technology Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Recombinant DNA Technology Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant DNA Technology Market Drivers
1.6.2 Recombinant DNA Technology Market Restraints
1.6.3 Recombinant DNA Technology Trends Analysis
2 Company Profiles
2.1 Monsanto Company
2.1.1 Monsanto Company Details
2.1.2 Monsanto Company Major Business
2.1.3 Monsanto Company Recombinant DNA Technology Product and Solutions
2.1.4 Monsanto Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Monsanto Company Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Recombinant DNA Technology Product and Solutions
2.2.4 Roche Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Recombinant DNA Technology Product and Solutions
2.3.4 Biogen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Recombinant DNA Technology Product and Solutions
2.4.4 Amgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Recombinant DNA Technology Product and Solutions
2.5.4 Novartis Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Recombinant DNA Technology Product and Solutions
2.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly and Company Recent Developments and Future Plans
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Recombinant DNA Technology Product and Solutions
2.7.4 GenScript Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GenScript Recent Developments and Future Plans
2.8 Pfizer Inc.
2.8.1 Pfizer Inc. Details
2.8.2 Pfizer Inc. Major Business
2.8.3 Pfizer Inc. Recombinant DNA Technology Product and Solutions
2.8.4 Pfizer Inc. Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pfizer Inc. Recent Developments and Future Plans
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Recombinant DNA Technology Product and Solutions
2.9.4 Novo Nordisk Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novo Nordisk Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Recombinant DNA Technology Product and Solutions
2.10.4 Sanofi Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Recombinant DNA Technology Product and Solutions
2.11.4 Merck KGaA Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Merck KGaA Recent Developments and Future Plans
2.12 Profacgen
2.12.1 Profacgen Details
2.12.2 Profacgen Major Business
2.12.3 Profacgen Recombinant DNA Technology Product and Solutions
2.12.4 Profacgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Profacgen Recent Developments and Future Plans
2.13 Biocon
2.13.1 Biocon Details
2.13.2 Biocon Major Business
2.13.3 Biocon Recombinant DNA Technology Product and Solutions
2.13.4 Biocon Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Biocon Recent Developments and Future Plans
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Recombinant DNA Technology Product and Solutions
2.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 GlaxoSmithKline Recent Developments and Future Plans
2.15 Cibus
2.15.1 Cibus Details
2.15.2 Cibus Major Business
2.15.3 Cibus Recombinant DNA Technology Product and Solutions
2.15.4 Cibus Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Cibus Recent Developments and Future Plans
2.16 Horizon Discovery Group
2.16.1 Horizon Discovery Group Details
2.16.2 Horizon Discovery Group Major Business
2.16.3 Horizon Discovery Group Recombinant DNA Technology Product and Solutions
2.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Horizon Discovery Group Recent Developments and Future Plans
2.17 New England Biolabs
2.17.1 New England Biolabs Details
2.17.2 New England Biolabs Major Business
2.17.3 New England Biolabs Recombinant DNA Technology Product and Solutions
2.17.4 New England Biolabs Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 New England Biolabs Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Recombinant DNA Technology Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Recombinant DNA Technology Players Market Share
3.2.2 Top 10 Recombinant DNA Technology Players Market Share
3.2.3 Market Competition Trend
3.3 Recombinant DNA Technology Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Recombinant DNA Technology Revenue and Market Share by Type (2016-2021)
4.2 Global Recombinant DNA Technology Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Recombinant DNA Technology Revenue Market Share by Application (2016-2021)
5.2 Recombinant DNA Technology Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Recombinant DNA Technology Revenue by Type (2016-2026)
6.2 North America Recombinant DNA Technology Revenue by Application (2016-2026)
6.3 North America Recombinant DNA Technology Market Size by Country
6.3.1 North America Recombinant DNA Technology Revenue by Country (2016-2026)
6.3.2 United States Recombinant DNA Technology Market Size and Forecast (2016-2026)
6.3.3 Canada Recombinant DNA Technology Market Size and Forecast (2016-2026)
6.3.4 Mexico Recombinant DNA Technology Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Recombinant DNA Technology Revenue by Type (2016-2026)
7.2 Europe Recombinant DNA Technology Revenue by Application (2016-2026)
7.3 Europe Recombinant DNA Technology Market Size by Country
7.3.1 Europe Recombinant DNA Technology Revenue by Country (2016-2026)
7.3.2 Germany Recombinant DNA Technology Market Size and Forecast (2016-2026)
7.3.3 France Recombinant DNA Technology Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Recombinant DNA Technology Market Size and Forecast (2016-2026)
7.3.5 Russia Recombinant DNA Technology Market Size and Forecast (2016-2026)
7.3.6 Italy Recombinant DNA Technology Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Recombinant DNA Technology Revenue by Type (2016-2026)
8.2 Asia-Pacific Recombinant DNA Technology Revenue by Application (2016-2026)
8.3 Asia-Pacific Recombinant DNA Technology Market Size by Region
8.3.1 Asia-Pacific Recombinant DNA Technology Revenue by Region (2016-2026)
8.3.2 China Recombinant DNA Technology Market Size and Forecast (2016-2026)
8.3.3 Japan Recombinant DNA Technology Market Size and Forecast (2016-2026)
8.3.4 South Korea Recombinant DNA Technology Market Size and Forecast (2016-2026)
8.3.5 India Recombinant DNA Technology Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Recombinant DNA Technology Market Size and Forecast (2016-2026)
8.3.7 Australia Recombinant DNA Technology Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Recombinant DNA Technology Revenue by Type (2016-2026)
9.2 South America Recombinant DNA Technology Revenue by Application (2016-2026)
9.3 South America Recombinant DNA Technology Market Size by Country
9.3.1 South America Recombinant DNA Technology Revenue by Country (2016-2026)
9.3.2 Brazil Recombinant DNA Technology Market Size and Forecast (2016-2026)
9.3.3 Argentina Recombinant DNA Technology Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Recombinant DNA Technology Revenue by Type (2016-2026)
10.2 Middle East & Africa Recombinant DNA Technology Revenue by Application (2016-2026)
10.3 Middle East & Africa Recombinant DNA Technology Market Size by Country
10.3.1 Middle East & Africa Recombinant DNA Technology Revenue by Country (2016-2026)
10.3.2 Turkey Recombinant DNA Technology Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Recombinant DNA Technology Market Size and Forecast (2016-2026)
10.3.4 UAE Recombinant DNA Technology Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Recombinant DNA Technology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Recombinant DNA Technology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Recombinant DNA Technology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Recombinant DNA Technology Revenue (USD Million) by Region (2016-2021)
Table 5. Global Recombinant DNA Technology Revenue Market Share by Region (2021-2026)
Table 6. Monsanto Company Corporate Information, Head Office, and Major Competitors
Table 7. Monsanto Company Major Business
Table 8. Monsanto Company Recombinant DNA Technology Product and Solutions
Table 9. Monsanto Company Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Recombinant DNA Technology Product and Solutions
Table 13. Roche Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Biogen Corporate Information, Head Office, and Major Competitors
Table 15. Biogen Major Business
Table 16. Biogen Recombinant DNA Technology Product and Solutions
Table 17. Biogen Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Amgen Corporate Information, Head Office, and Major Competitors
Table 19. Amgen Major Business
Table 20. Amgen Recombinant DNA Technology Product and Solutions
Table 21. Amgen Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Major Business
Table 24. Novartis Recombinant DNA Technology Product and Solutions
Table 25. Novartis Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly and Company Major Business
Table 28. Eli Lilly and Company Recombinant DNA Technology Product and Solutions
Table 29. Eli Lilly and Company Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GenScript Corporate Information, Head Office, and Major Competitors
Table 31. GenScript Major Business
Table 32. GenScript Recombinant DNA Technology Product and Solutions
Table 33. GenScript Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Inc. Major Business
Table 36. Pfizer Inc. Recombinant DNA Technology Product and Solutions
Table 37. Pfizer Inc. Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 39. Novo Nordisk Major Business
Table 40. Novo Nordisk Recombinant DNA Technology Product and Solutions
Table 41. Novo Nordisk Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sanofi Corporate Information, Head Office, and Major Competitors
Table 43. Sanofi Major Business
Table 44. Sanofi Recombinant DNA Technology Product and Solutions
Table 45. Sanofi Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 47. Merck KGaA Major Business
Table 48. Merck KGaA Recombinant DNA Technology Product and Solutions
Table 49. Merck KGaA Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Profacgen Corporate Information, Head Office, and Major Competitors
Table 51. Profacgen Major Business
Table 52. Profacgen Recombinant DNA Technology Product and Solutions
Table 53. Profacgen Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Biocon Corporate Information, Head Office, and Major Competitors
Table 55. Biocon Major Business
Table 56. Biocon Recombinant DNA Technology Product and Solutions
Table 57. Biocon Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 59. GlaxoSmithKline Major Business
Table 60. GlaxoSmithKline Recombinant DNA Technology Product and Solutions
Table 61. GlaxoSmithKline Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Cibus Corporate Information, Head Office, and Major Competitors
Table 63. Cibus Major Business
Table 64. Cibus Recombinant DNA Technology Product and Solutions
Table 65. Cibus Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Horizon Discovery Group Corporate Information, Head Office, and Major Competitors
Table 67. Horizon Discovery Group Major Business
Table 68. Horizon Discovery Group Recombinant DNA Technology Product and Solutions
Table 69. Horizon Discovery Group Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 71. New England Biolabs Major Business
Table 72. New England Biolabs Recombinant DNA Technology Product and Solutions
Table 73. New England Biolabs Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Recombinant DNA Technology Revenue (USD Million) by Players (2019-2021)
Table 75. Global Recombinant DNA Technology Revenue Share by Players (2019-2021)
Table 76. Breakdown of Recombinant DNA Technology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Recombinant DNA Technology Players Head Office, Products and Services Provided
Table 78. Recombinant DNA Technology Mergers & Acquisitions in the Past Five Years
Table 79. Recombinant DNA Technology New Entrants and Expansion Plans
Table 80. Global Recombinant DNA Technology Revenue (USD Million) by Type (2016-2021)
Table 81. Global Recombinant DNA Technology Revenue Share by Type (2016-2021)
Table 82. Global Recombinant DNA Technology Revenue Forecast by Type (2021-2026)
Table 83. Global Recombinant DNA Technology Revenue by Application (2016-2021)
Table 84. Global Recombinant DNA Technology Revenue Forecast by Application (2021-2026)
Table 85. North America Recombinant DNA Technology Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Recombinant DNA Technology Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Recombinant DNA Technology Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Recombinant DNA Technology Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Recombinant DNA Technology Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Recombinant DNA Technology Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Recombinant DNA Technology Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Recombinant DNA Technology Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Recombinant DNA Technology Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Recombinant DNA Technology Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Recombinant DNA Technology Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Recombinant DNA Technology Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Recombinant DNA Technology Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Recombinant DNA Technology Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Recombinant DNA Technology Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Recombinant DNA Technology Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Recombinant DNA Technology Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Recombinant DNA Technology Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Recombinant DNA Technology Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Recombinant DNA Technology Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Recombinant DNA Technology Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Recombinant DNA Technology Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Recombinant DNA Technology Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Recombinant DNA Technology Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Recombinant DNA Technology Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Recombinant DNA Technology Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Recombinant DNA Technology Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Recombinant DNA Technology Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Recombinant DNA Technology Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Recombinant DNA Technology Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Recombinant DNA Technology Picture
Figure 2. Global Recombinant DNA Technology Revenue Market Share by Type in 2020
Figure 3. Therapeutic Agent
Figure 4. Vaccine
Figure 5. Biotech Crops
Figure 6. Specialty Chemicals
Figure 7. Recombinant DNA Technology Revenue Market Share by Application in 2020
Figure 8. Biotechnology and Pharmaceutical Companies Picture
Figure 9. Academic & Government Research Institutes Picture
Figure 10. Others Picture
Figure 11. Global Recombinant DNA Technology Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Recombinant DNA Technology Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Recombinant DNA Technology Revenue Market Share by Region (2016-2026)
Figure 14. Global Recombinant DNA Technology Revenue Market Share by Region in 2020
Figure 15. North America Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Recombinant DNA Technology Market Drivers
Figure 20. Recombinant DNA Technology Market Restraints
Figure 21. Recombinant DNA Technology Market Trends
Figure 22. Monsanto Company Recent Developments and Future Plans
Figure 23. Roche Recent Developments and Future Plans
Figure 24. Biogen Recent Developments and Future Plans
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Eli Lilly and Company Recent Developments and Future Plans
Figure 28. GenScript Recent Developments and Future Plans
Figure 29. Pfizer Inc. Recent Developments and Future Plans
Figure 30. Novo Nordisk Recent Developments and Future Plans
Figure 31. Sanofi Recent Developments and Future Plans
Figure 32. Merck KGaA Recent Developments and Future Plans
Figure 33. Profacgen Recent Developments and Future Plans
Figure 34. Biocon Recent Developments and Future Plans
Figure 35. GlaxoSmithKline Recent Developments and Future Plans
Figure 36. Cibus Recent Developments and Future Plans
Figure 37. Horizon Discovery Group Recent Developments and Future Plans
Figure 38. New England Biolabs Recent Developments and Future Plans
Figure 40. Global Recombinant DNA Technology Revenue Share by Players in 2020
Figure 41. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Recombinant DNA Technology Revenue Market Share in 2020
Figure 43. Global Top 10 Players Recombinant DNA Technology Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Recombinant DNA Technology Revenue Share by Type in 2020
Figure 46. Global Recombinant DNA Technology Market Share Forecast by Type (2021-2026)
Figure 47. Global Recombinant DNA Technology Revenue Share by Application in 2020
Figure 48. Global Recombinant DNA Technology Market Share Forecast by Application (2021-2026)
Figure 49. North America Recombinant DNA Technology Sales Market Share by Type (2016-2026)
Figure 50. North America Recombinant DNA Technology Sales Market Share by Application (2016-2026)
Figure 51. North America Recombinant DNA Technology Revenue Market Share by Country (2016-2026)
Figure 52. United States Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Recombinant DNA Technology Sales Market Share by Type (2016-2026)
Figure 56. Europe Recombinant DNA Technology Sales Market Share by Application (2016-2026)
Figure 57. Europe Recombinant DNA Technology Revenue Market Share by Country (2016-2026)
Figure 58. Germany Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Recombinant DNA Technology Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Recombinant DNA Technology Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Recombinant DNA Technology Revenue Market Share by Region (2016-2026)
Figure 66. China Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Recombinant DNA Technology Sales Market Share by Type (2016-2026)
Figure 73. South America Recombinant DNA Technology Sales Market Share by Application (2016-2026)
Figure 74. South America Recombinant DNA Technology Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Recombinant DNA Technology Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Recombinant DNA Technology Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Recombinant DNA Technology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の組換えDNA技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant DNA Technology Market The global Recombinant DNA Technology market size is projected to reach US$ 644 million by 2026, from US$ 490.8 million in 2019, at a CAGR of 3.9% during 2021-2026. With industry-standard accuracy in analysis and high data integr…- 世界の新型コロナウイルス感染症組換えタンパク質ワクチン市場規模・現状・予測（2021年-2027年） Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-ol…
- 世界の組換え治療用抗体＆タンパク質市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 世界の組換え抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant Antibody Market The global Recombinant Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…